GE HealthCare Technologies Inc.
GEHC
Rankning i aktier
#771
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Aktiekurs
$69.08
Marknadsvärde
$31.20B
Förändring (1 dag)
-1.64%
Förändring (1 år)
-9.22%
Land
US
Handel GE HealthCare Technologies Inc. (GEHC)
Kategori
Healthcare
Antal utestående aktier för GE HealthCare Technologies Inc. (GEHC)
Antal utestående aktier per June 2026: 453.00M
Enligt de senaste finansiella rapporterna och aktiekursen för GE HealthCare Technologies Inc. är det aktuella antalet utestående aktier 453.00M. I slutet av December 2024 hade företaget 456.00M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för GE HealthCare Technologies Inc. (GEHC) från 2019 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 453.00M | -0.77% |
| 2025 | 456.52M | 0.11% |
| 2024 | 456.00M | 0.22% |
| 2023 | 455.00M | 0.24% |
| 2022 | 453.93M | -0.17% |
| 2021 | 454.71M | 0.00% |
| 2020 | 454.71M | 0.00% |
| 2019 | 454.71M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 104.47M | -76.94% |
AU
|
|
| 205.38M | -54.66% |
US
|
|
| 179.92M | -60.28% |
US
|
|
| 129.98M | -71.31% |
US
|
|
| - | - |
US
|
